Kura Oncology Inc (NAS:KURA)
$ 11.04 -0.13 (-1.16%) Market Cap: 858.51 Mil Enterprise Value: 419.84 Mil PE Ratio: 0 PB Ratio: 2.03 GF Score: 42/100

Q3 2019 Kura Oncology Inc Earnings Call Transcript

Nov 05, 2019 / 09:30PM GMT
Release Date Price: $14.87 (-3.19%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Third Quarter 2019 Kura Oncology Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Pete de Spain, Vice President, Investor Relations at Kura Oncology. Please go ahead.

Pete De Spain
Kura Oncology, Inc. - VP of IR & Corporate Communications

Thank you, Sarah. Good afternoon, and welcome to

Kura Oncology's Third Quarter 2019 Conference Call. Joining me on the call from Kura are Dr. Troy Wilson, our President and Chief Executive Officer; and Dr. Marc Grasso, our Chief Financial Officer and Chief Business Officer. Dr. Antonio Gualberto, our Chief Medical Officer and Head of Development, is also with us and available to answer questions.

Before I turn the call over to Dr. Wilson, I would like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot